Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2026-01-19 @ 3:19 AM
Study NCT ID:
NCT01204866
Status:
COMPLETED
Last Update Posted:
2010-09-24
First Post:
2010-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use
Sponsor:
PharmAthene, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0036-08-05-A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Pharmathene, Inc.
Old Organization:
Clinical Project Manager